What is Agios Pharmaceuticals's investment proceeds?

Agios Pharmaceuticals (AGIO) reported investment proceeds of $290.26M in Q1 2026.

How has Agios Pharmaceuticals's investment proceeds changed year-over-year?

Agios Pharmaceuticals's investment proceeds increased by 0.7% year-over-year, from $288.26M to $290.26M.

What is the long-term trend for Agios Pharmaceuticals's investment proceeds?

Over 4 years (2021 to 2025), Agios Pharmaceuticals's investment proceeds has grown at a 5.6% compound annual growth rate (CAGR), from $829.8M to $1.03B.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Agios Pharmaceuticals AGIO Investment Proceeds

Investment Proceeds at other companies

IncyteINCY

$0-100%

BioMarin PharmaceuticalsBMRN

$767.28M+886%

Disc MedicineIRON

$152.07M+102%

PrecigenPGEN

$55.1M+1,105%

Ultragenyx PharmaceuticalRARE

$88M-35.8%

BioCryst PharmaceuticalsBCRX

$221.24M+191%

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's investment proceeds?: Agios Pharmaceuticals (AGIO) reported investment proceeds of $290.26M in Q1 2026.
How has Agios Pharmaceuticals's investment proceeds changed year-over-year?: Agios Pharmaceuticals's investment proceeds increased by 0.7% year-over-year, from $288.26M to $290.26M.
What is the long-term trend for Agios Pharmaceuticals's investment proceeds?: Over 4 years (2021 to 2025), Agios Pharmaceuticals's investment proceeds has grown at a 5.6% compound annual growth rate (CAGR), from $829.8M to $1.03B.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.